Jane Street’s Tema Oncology ETF CANC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.83M Buy
43,450
+15,913
+58% +$673K ﹤0.01% 5340
2026
Q2
$1.14M Sell
27,537
-61,044
-69% -$2.31M ﹤0.01% 6265
2026
Q1
$3.25M Buy
88,581
+56,885
+179% +$2.07M ﹤0.01% 4201
2025
Q4
$1.1M Buy
+31,696
New +$1.03M ﹤0.01% 5928
2025
Q3
– Sell
-14,104
Closed -$349K – 10833
2025
Q2
$349K Buy
14,104
+5,275
+60% +$127K ﹤0.01% 7579
2025
Q1
$213K Buy
+8,829
New +$222K ﹤0.01% 8362
2024
Q4
– Sell
-44,311
Closed -$1.26M – 9460
2024
Q3
$1.26M Sell
44,311
-98,880
-69% -$2.84M ﹤0.01% 5411
2024
Q2
$3.86M Buy
143,191
+135,172
+1,686% +$3.65M ﹤0.01% 3376
2024
Q1
$225K Sell
8,019
-978
-11% -$26.6K ﹤0.01% 8008
2023
Q4
$237K Buy
+8,997
New +$211K ﹤0.01% 7973

Other funds holding CANC

Jane Street's CANC Position: Q3 2026 in Review

Jane Street increased its Tema Oncology ETF (CANC) stake by 58% in Q3 2026, buying an estimated $673K and bringing the position to 43,450 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #5340.

Jane Street first reported a position in CANC in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.86M in Q2 2024. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.

  • Jane Street held 43,450 shares of Tema Oncology ETF worth $1.83M as of Q3 2026.
  • Jane Street bought 15,913 Tema Oncology ETF shares in Q3 2026, an estimated $673K.
  • Tema Oncology ETF made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #5340 holding.
  • Jane Street first reported a position in Tema Oncology ETF in Q4 2023 and has held it in 10 quarters since.
  • Jane Street's Tema Oncology ETF position peaked at $3.86M in Q2 2024.
  • 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.